Cargando…

Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population

BACKGROUND: Statin therapy in multimorbid older individuals with polypharmacy is controversial, particularly in primary prevention of cardiovascular disease. Thereby, physicians must weigh potential benefits against potential side effects, drug-drug interactions, and limited life expectancy. AIM: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adam, Luise, Baretella, Oliver, Feller, Martin, Blum, Manuel Raphael, Papazoglou, Dimitrios David, Boland, Benoit, Aujesky, Drahomir, Baggio, Stéphanie, Rodondi, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551156/ https://www.ncbi.nlm.nih.gov/pubmed/37808883 http://dx.doi.org/10.3389/fcvm.2023.1236547

Ejemplares similares

Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial
por: Blum, Manuel R, et al.
Publicado: (2021)

Cross-sectional study on the prevalence of influenza and pneumococcal vaccination and its association with health conditions and risk factors among hospitalized multimorbid older patients
por: Papazoglou, Dimitrios David, et al.
Publicado: (2021)

Benzodiazepine Receptor Agonists Use and Cessation Among Multimorbid Older Adults with Polypharmacy: Secondary Analysis from the OPERAM Trial
por: Sibille, François-Xavier, et al.
Publicado: (2023)

Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trial
por: Adam, Luise, et al.
Publicado: (2019)

Multimorbidity and Quality of Preventive Care in Swiss University Primary Care Cohorts
por: Streit, Sven, et al.
Publicado: (2014)

Cost-effectiveness of a structured medication review approach for multimorbid older adults: Within-trial analysis of the OPERAM study
por: Salari, Paola, et al.
Publicado: (2022)

Experience of hospital-initiated medication changes in older people with multimorbidity: a multicentre mixed-methods study embedded in the OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM) trial
por: Thevelin, Stefanie, et al.
Publicado: (2022)

Statin therapy and recurrent venous thromboembolism in the elderly: a prospective cohort study
por: Kronenberg, Regula Monika, et al.
Publicado: (2019)

HOSPITAL Score and LACE Index to Predict Mortality in Multimorbid Older Patients
por: Aubert, Carole E., et al.
Publicado: (2022)

Intervention protocol: OPtimising thERapy to prevent avoidable hospital Admission in the Multi-morbid elderly (OPERAM): a structured medication review with support of a computerised decision support system
por: Crowley, Erin K., et al.
Publicado: (2020)

Association between diabetes overtreatment in older multimorbid patients and clinical outcomes: an ancillary European multicentre study
por: Christiaens, Antoine, et al.
Publicado: (2023)

Development of a core outcome set for medication review in older patients with multimorbidity and polypharmacy: a study protocol
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2017)

Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Corrigendum: Multimorbidity and Polypharmacy in Chinese Emergency Department Patients With Atrial Fibrillation and Impacts on Clinical Outcomes
por: Wang, Juan, et al.
Publicado: (2022)

Comparison of 6 Mortality Risk Scores for Prediction of 1-Year Mortality Risk in Older Adults With Multimorbidity
por: Schneider, Claudio, et al.
Publicado: (2022)

Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial
por: Zerah, Lorène, et al.
Publicado: (2021)

Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
por: Aubert, Carole E., et al.
Publicado: (2023)

Predictors of 1‐year drug‐related admissions in older multimorbid hospitalized adults
por: Aubert, Carole E., et al.
Publicado: (2022)

Impact of multimorbidity and polypharmacy on the management of patients with atrial fibrillation: insights from the BALKAN-AF survey
por: Kozieł, Monika, et al.
Publicado: (2020)

Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study
por: Guo, Xueyuan, et al.
Publicado: (2022)

Low Reporting of Cointerventions in Recent Cardiovascular Clinical Trials: A Systematic Review
por: Moutzouri, Elisavet, et al.
Publicado: (2020)

Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study
por: Mueller, Carolin, et al.
Publicado: (2017)

Dental status and its correlation with polypharmacy and multimorbidity in a Swiss nursing home population: a cross-sectional study
por: Anliker, Noemi, et al.
Publicado: (2023)

Multimorbidity and healthcare resource utilization in Switzerland: a multicentre cohort study
por: Aubert, Carole E., et al.
Publicado: (2019)

Inadequate Reporting of Cointerventions, Other Methodological Factors, and Treatment Estimates in Cardiovascular Trials: A Meta-Epidemiological Study
por: Bührer, Jonas, et al.
Publicado: (2023)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy
por: Bhadhuri, Arjun, et al.
Publicado: (2020)

Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
por: Ferrazzini, Elisa, et al.
Publicado: (2022)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey
por: Rozsnyai, Zsofia, et al.
Publicado: (2020)

Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2023)

Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study
por: Hofmann, Eveline, et al.
Publicado: (2016)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Life expectancy in multimorbid older adults: Why it matters for preventive care
por: Gastens, V, et al.
Publicado: (2022)

Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment?
por: Jegerlehner, Sabrina, et al.
Publicado: (2019)

Association between computed tomography obstruction index and mortality in elderly patients with acute pulmonary embolism: A prospective validation study
por: Méan, Marie, et al.
Publicado: (2017)

Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study
por: Jegerlehner, Sabrina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nbctrtbg34r3mit05bnkpcmmn2